More on BiIB
Data
Financials
Upcoming Events
News
Click line-items for a historical chart and %
| Net income | 3.05B |
| Depreciation and amortization of property, plant and equipment and intangible assets | |
| Acquired in-process research and development | |
| Share-based compensation | 117.8M |
| Fair value adjustment of contingent consideration | |
| Excess tax benefit from share-based compensation | |
| Deferred income taxes | -56.8M |
| Write-down of inventory to net realizable value | |
| Impairment of marketable securities, investments and other assets | |
| Non-cash interest (income) expense, foreign exchange remeasurement loss (gain), net and other | |
| Realized gain on sale of marketable securities and strategic investments | |
| Accounts receivable | -238.1M |
| Due from unconsolidated joint business | |
| Inventory | -155.1M |
| Other assets | |
| Accrued expenses and other current liabilities | -223.2M |
| Other liabilities and taxes payable | |
| Net cash flows provided by operating activities | 2.95B |
| Proceeds from sales and maturities of marketable securities | |
| Purchases of marketable securities | |
| Acquisitions | 0 |
| Purchases of property, plant and equipment | -434M |
| Purchases of intangible assets | |
| Purchases of other investments | |
| Proceeds from the sale of strategic investments | |
| Net cash flows (used in) provided by investing activities | -1.9B |
| Purchase of treasury stock | -348.9M |
| Proceeds from the issuance of stock for share-based compensation arrangements | |
| Excess tax benefit from share-based compensation | 11.9M |
| Change in cash overdraft | |
| Net contributions (to) from noncontrolling interests | |
| Repayments of borrowings | |
| Repayments on financing arrangement for the sale of the San Diego facility | |
| Net cash flows used in financing activities | -266.6M |
| Net increase in cash and cash equivalents | 776.1M |
| Effect of exchange rate changes on cash and cash equivalents | 700K |
| Cash and cash equivalents, beginning of the period | 1.31B |
| Cash and cash equivalents, end of the period | 2.08B |
Entities mentioned with BIIB
- Twitter | View Related Stories »
- FDA | View Related Stories »
- Earnings | View Related Stories »
- Definitive Agreement | View Related Stories »
- ARK | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- Options | View Related Stories »
- Show More...
